Literature DB >> 18662729

Iontophoresis of dexamethasone phosphate: competition with chloride ions.

J-P Sylvestre1, C Díaz-Marín, M B Delgado-Charro, R H Guy.   

Abstract

The objective was to study the competition of chloride released from a Ag/AgCl cathode on the iontophoretic delivery of dexamethasone phosphate (Dex-Phos). Iontophoresis of Dex-Phos was performed in side-by-side diffusion cells (0.78 cm(2)) using pig skin. A 0.3 mA constant current was applied via Ag/AgCl electrodes. The amounts of Dex-Phos and dexamethasone (Dex) were also quantified in the stratum corneum (SC), using tape-stripping, after passive and iontophoretic delivery. The profiles of Dex-Phos and Dex, as a function of position in the SC, were deduced. The iontophoretic delivery of Dex-Phos from pure water was unaffected by the accumulation of Cl- released by the donor cathode when the drug's concentration was 4.25 mM to 17 mM. At 0.85 mM, however, Cl- competition was significant and the drug flux was significantly reduced. Formulation of the drug in the presence of Cl- resulted in a non-linear dependence of flux on the molar fraction of the drug. Tape-stripping experiments confirmed the enhanced delivery of Dex-Phos by iontophoresis relative to passive diffusion, with Dex-Phos concentration greater inside the barrier post-iontophoresis than that in the donor. The latter observation could explain the robustness of Dex-Phos delivery to the presence of Cl- in the donor solution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662729      PMCID: PMC2574231          DOI: 10.1016/j.jconrel.2008.07.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

Review 1.  Reverse iontophoresis for non-invasive transdermal monitoring.

Authors:  Benoît Leboulanger; Richard H Guy; M Begoña Delgado-Charro
Journal:  Physiol Meas       Date:  2004-06       Impact factor: 2.833

Review 2.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

3.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

4.  Pharmacokinetic and local tissue disposition of [14C]sodium diclofenac following iontophoresis and systemic administration in rabbits.

Authors:  X Hui; A Anigbogu; P Singh; G Xiong; N Poblete; P Liu; H I Maibach
Journal:  J Pharm Sci       Date:  2001-09       Impact factor: 3.534

Review 5.  The role of electroosmotic flow in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

6.  Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

7.  Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man.

Authors:  Christophe Herkenne; Aarti Naik; Yogeshvar N Kalia; Jonathan Hadgraft; Richard H Guy
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

8.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

9.  In vitro optimization of dexamethasone phosphate delivery by iontophoresis.

Authors:  Jean-Philippe Sylvestre; Richard H Guy; M Begoña Delgado-Charro
Journal:  Phys Ther       Date:  2008-08-21

10.  Transport numbers in transdermal iontophoresis.

Authors:  Blaise Mudry; Richard H Guy; M Begoña Delgado-Charro
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

View more
  1 in total

1.  Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy.

Authors:  Julie Dutet; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.